Search research articles
Contact Us
Filters
Showing results (121-130 of 298) with videos related to
Page
of 30
Sort By:
British Journal of Haematology
|
December 15, 2005
Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation: a genetic and pathological correlation
Sherrie L Perkins, Diane Pickering, Eric J Lowe, et al.
Haematologica
|
June 4, 2026
Immune checkpoint therapy in pediatric and adolescent lymphomas
David J Hoogstra, Ana C Xavier, Paul Harker-Murray, et al.
Journal of Hematotherapy & Stem Cell Research
|
May 2, 2002
Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients
Kenneth R Meehan, Rebecca Slack, Edmund Gehan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 6, 2015
Revised International Pediatric Non-Hodgkin Lymphoma Staging System
Angelo Rosolen, Sherrie L Perkins, C Ross Pinkerton, et al.
Pediatric Blood & Cancer
|
August 30, 2005
State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY
Nyla A Heerema, Alain Bernheim, Megan S Lim, et al.
Journal of Pediatric Hematology/Oncology
|
February 7, 2003
Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primers
Vani Sabesan, Mitchell S Cairo, Mark A Lones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 6, 2015
International Pediatric Non-Hodgkin Lymphoma Response Criteria
John T Sandlund, R Paul Guillerman, Sherrie L Perkins, et al.
Journal for Immunotherapy of Cancer
|
July 10, 2021
Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2<sup>+</sup> pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice
Yaya Chu, Gaurav Nayyar, Susiyan Jiang, et al.
Pediatric Blood & Cancer
|
April 24, 2019
IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials
Karen M Chisholm, Jeffrey Mohlman, Michael Liew, et al.
Oncotarget
|
June 2, 2020
Protein phosphatase 1 regulatory subunit 1A regulates cell cycle progression in Ewing sarcoma
Wen Luo, Changxin Xu, Sarah Phillips, et al.
Page
of 30
Search research articles
Search
Showing results (121-130 of 298) with videos related to
Sort By:
Page
of 30
British Journal of Haematology
|
December 15, 2005
Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation: a genetic and pathological correlation
Sherrie L Perkins, Diane Pickering, Eric J Lowe, et al.
Haematologica
|
June 4, 2026
Immune checkpoint therapy in pediatric and adolescent lymphomas
David J Hoogstra, Ana C Xavier, Paul Harker-Murray, et al.
Journal of Hematotherapy & Stem Cell Research
|
May 2, 2002
Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients
Kenneth R Meehan, Rebecca Slack, Edmund Gehan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 6, 2015
Revised International Pediatric Non-Hodgkin Lymphoma Staging System
Angelo Rosolen, Sherrie L Perkins, C Ross Pinkerton, et al.
Pediatric Blood & Cancer
|
August 30, 2005
State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY
Nyla A Heerema, Alain Bernheim, Megan S Lim, et al.
Journal of Pediatric Hematology/Oncology
|
February 7, 2003
Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primers
Vani Sabesan, Mitchell S Cairo, Mark A Lones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 6, 2015
International Pediatric Non-Hodgkin Lymphoma Response Criteria
John T Sandlund, R Paul Guillerman, Sherrie L Perkins, et al.
Journal for Immunotherapy of Cancer
|
July 10, 2021
Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2<sup>+</sup> pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice
Yaya Chu, Gaurav Nayyar, Susiyan Jiang, et al.
Pediatric Blood & Cancer
|
April 24, 2019
IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials
Karen M Chisholm, Jeffrey Mohlman, Michael Liew, et al.
Oncotarget
|
June 2, 2020
Protein phosphatase 1 regulatory subunit 1A regulates cell cycle progression in Ewing sarcoma
Wen Luo, Changxin Xu, Sarah Phillips, et al.
Page
of 30